These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 21881050

  • 1. The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome.
    D'Souza A, Hayman SR, Buadi F, Mauermann M, Lacy MQ, Gertz MA, Kyle RA, Kumar S, Greipp PR, Lust JA, Russell SJ, Zeldenrust S, Dingli D, Witzig TE, Rajkumar SV, Dispenzieri A.
    Blood; 2011 Oct 27; 118(17):4663-5. PubMed ID: 21881050
    [Abstract] [Full Text] [Related]

  • 2. Vascular endothelial growth factor as a predictive marker for POEMS syndrome treatment response: retrospective cohort study.
    Misawa S, Sato Y, Katayama K, Hanaoka H, Sawai S, Beppu M, Nomura F, Shibuya K, Sekiguchi Y, Iwai Y, Watanabe K, Amino H, Ohwada C, Takeuchi M, Sakaida E, Nakaseko C, Kuwabara S.
    BMJ Open; 2015 Nov 11; 5(11):e009157. PubMed ID: 26560063
    [Abstract] [Full Text] [Related]

  • 3. Clinical characteristics and the long-term outcome of patients with atypical POEMS syndrome variant with undetectable monoclonal gammopathy.
    He T, Zhao A, Zhao H, Cai H, Feng J, Zhang L, Cao X, Zhou D, Li J.
    Ann Hematol; 2019 Mar 11; 98(3):735-743. PubMed ID: 30612232
    [Abstract] [Full Text] [Related]

  • 4. Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis.
    Scarlato M, Previtali SC, Carpo M, Pareyson D, Briani C, Del Bo R, Nobile-Orazio E, Quattrini A, Comi GP.
    Brain; 2005 Aug 11; 128(Pt 8):1911-20. PubMed ID: 15975949
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. An atypical presentation of POEMS syndrome with IgG kappa type M protein and normal VEGF level: Case report and review of literature.
    Pulivarthi S, Gurram MK.
    J Cancer Res Ther; 2018 Aug 11; 14(3):679-681. PubMed ID: 29893339
    [Abstract] [Full Text] [Related]

  • 13. Correlation between peripapillary retinal thickness and serum level of vascular endothelial growth factor in patients with POEMS syndrome.
    Yokouchi H, Baba T, Misawa S, Sawai S, Kitahashi M, Oshitari T, Kuwabara S, Yamamoto S.
    Br J Ophthalmol; 2016 Jul 11; 100(7):897-901. PubMed ID: 26504179
    [Abstract] [Full Text] [Related]

  • 14. Correlation between serum level of vascular endothelial growth factor and subfoveal choroidal thickness in patients with POEMS syndrome.
    Yokouchi H, Baba T, Misawa S, Sawai S, Beppu M, Kitahashi M, Oshitari T, Kuwabara S, Yamamoto S.
    Graefes Arch Clin Exp Ophthalmol; 2015 Oct 11; 253(10):1641-6. PubMed ID: 25367833
    [Abstract] [Full Text] [Related]

  • 15. Serum vascular endothelial growth factor (VEGF) level can be used as a diagnostic marker in POEMS syndrome.
    Jang HS, Parratt JDE, Tsang VHM, Coyle LA, Fernando SL.
    Pathology; 2018 Oct 11; 50(6):674-676. PubMed ID: 30082079
    [No Abstract] [Full Text] [Related]

  • 16. POEMS Syndrome: 2019 Update on diagnosis, risk-stratification, and management.
    Dispenzieri A.
    Am J Hematol; 2019 Jul 11; 94(7):812-827. PubMed ID: 31012139
    [Abstract] [Full Text] [Related]

  • 17. Alterations in choroidal vascular structures due to serum levels of vascular endothelial growth factor in patients with POEMS syndrome.
    Yokouchi H, Nagasato D, Mitamura Y, Egawa M, Tabuchi H, Misawa S, Kuwabara S, Baba T.
    Sci Rep; 2023 Jun 30; 13(1):10650. PubMed ID: 37391497
    [Abstract] [Full Text] [Related]

  • 18. [POEMS syndrome diagnosed by detection of M-protein on immunofixation and increased level of vascular endothelial growth factor].
    Hattori Y, Taguchi J, Imai N, Wasano K, Matsuura S, Koharazawa H, Ishigatsubo Y, Fujisawa S.
    Rinsho Ketsueki; 2011 Apr 30; 52(4):219-22. PubMed ID: 21566409
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The Peripheral Neuropathies of POEMS Syndrome and Castleman Disease.
    Mauermann ML.
    Hematol Oncol Clin North Am; 2018 Feb 30; 32(1):153-163. PubMed ID: 29157616
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.